Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze. (Q34500748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Serotonergic regulation of inhibitory avoidance and one-way escape in the rat elevated T-maze (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

H Zangrossi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M B Viana

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

C Bueno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

R L Nogueira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

F G Graeff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

Neuroscience & Biobehavioral Reviews

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

7-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

637-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

A review of central 5-HT receptors and their function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Computer analysis and quantification of periaqueductal grey-induced defence behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Benzodiazepines, appetite, and taste palatability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Benzodiazepine and serotonergic modulation of antipredator and conspecific defense

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Neurobiology of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Exploratory behavior models of anxiety in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

The elevated T-maze as an experimental model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Dual role of 5-HT in defense and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

5-HT-the disengaging transmitter?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Addition of d-fenfluramine to benzodiazepines produces a marked improvement in refractory panic disorder--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Panic disorder. Pathophysiology and drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Microinjections of methyl-beta-carboline-3-carboxylate into the dorsal raphe nucleus: behavioural consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

A risk-benefit assessment of buspirone in the treatment of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Animal models of ??anxiety??: where next?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

GABA mimetics decrease extracellular concentrations of 5-HIAA (as measured by in vivo voltammetry) in the dorsal raphe of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Differential expression of Fos protein in the rat brain induced by performance of avoidance or escape in the elevated T-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Controlling panic attacks with fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Fenfluramine provocation of anxiety in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Chlordiazepoxide and GABA injected into raphé dorsalis release the conditioned behavioural suppression induced in rats by a conflict procedure without nociceptive component.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

5-Hydroxytryptamine and punishment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Kainate microinjection into the dorsal raphe nucleus induces 5-HT release in the amygdala and periaqueductal gray.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

The elevated T-maze: a new animal model of anxiety and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Behavioral validation of the elevated T-maze, a new animal model of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900047-1

7 January 2021

10.1016/S0149-7634(01)00047-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11801289%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference